The Valley Desk

Clinical trial reportThe Journal of dermatologyPublished

Efficacy of guselkumab in difficult-to-treat psoriasis regions: Data from VOYAGE 1 and VOYAGE 2 Asian subpopulations

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
The Journal of dermatology
Published
Subject terms
Humans; Nail Diseases; Psoriasis; Immunoglobulin A; Biological Products; Antibodies, Monoclonal; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Antibodies, Monoclonal, Humanized; Adalimumab; Asian
PubMed ID
37341137
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal